SRX Global secures $11.67M note with CERo, permits up to $6.0M advances
SRX Global completed a secured financing with CERo Therapeutics Holdings under a Consolidated Senior Secured Promissory Note dated Aug. 27, 2026, consolidating $5.67M of prior notes and permitting up to $6.0M in new advances for $11.67M total.